214: Juul's doomsday, Merck's buyout plans, & the next Theranos verdict
The Readout Loud
00:00
Is This a Big Deal?
Sijen is a 30 billion dollar company, so we're probably talking about a dealin the neighborhood of forty billion dollars. One thing that's interesting about s jen is that major farmasuto companies tend to have kind of diversity of stock ownership. But sijen is different. The baker brothersaaasin firm has a huge stake in sejen. How does that effect the sort ofi game theory of a potential deal like this?
Transcript
Play full episode
